MODERATE TO SEVERE ASTHMA
Clinical trials for MODERATE TO SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New asthma drug shows promise in early safety trial
Disease control CompletedThis early-stage trial tested a drug called itolizumab (EQ001) in 18 adults with moderate-to-severe asthma that is not well controlled by standard treatments. The main goal was to see if the drug is safe and how the body processes it. Researchers also looked for early signs that …
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE1 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New asthma injection shows promise in early trial
Disease control CompletedThis early-phase study tested a new drug called RC1416 in 40 adults with moderate to severe asthma. Participants received a single injection of either the drug or a placebo. The main goal was to check safety and how the body processes the drug, with a preliminary look at whether …
Matched conditions: MODERATE TO SEVERE ASTHMA
Phase: PHASE1 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC